Human Crossveinless-2 is a novel inhibitor of bone morphogenetic proteins

Biochemical and Biophysical Research Communications

Volumn 315, Issue 2, 2004, Pages 272-280

  Binnerts, Minke E ^a   Wen, Xiaohui ^a   Canté Barrett, Kirsten ^a   Bright, Jessica ^a   Chen, Huang Tsu ^a   Asundi, Vinod ^a   Sattari, Peter ^a   Tang, Tom ^a   Boyle, Bryan ^a   Funk, Walter ^a   Rupp, Fabio ^a  

^a Nuvelo Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; HUMAN CROSSVEINLESS 2 PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BONE DEVELOPMENT; CARTILAGE CELL; CELL DIFFERENTIATION; CHONDROGENESIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; OSTEOBLAST; PREDICTION; PRIORITY JOURNAL; PROTEIN PURIFICATION;

DROSOPHILA MELANOGASTER;

EID: 10744233059     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.01.048     Document Type: Article

References (36)

1. Conley C.A., Silburn R., Singer M.A., Ralston A., Rohwer-Nutter D., Olson D.J., Gelbart W., Blair S.S. Crossveinless 2 contains cysteine-rich domains and is required for high levels of BMP-like activity during the formation of the cross veins in Drosophila. Development. 127:2000;3947-3959.
2. Fujii M., Takeda K., Imamura T., Aoki H., Sampath T.K., Enomoto S., Kawabata M., Kato M., Ichijo H., Miyazono K. Roles of bone morphogenetic protein type I receptors and Smad proteins in osteoblast and chondroblast differentiation. Mol. Biol. Cell. 10:1999;3801-3813.
3. Hogan B.L. Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev. 10:1996;1580-1594.
4. Thies R.S., Bauduy M., Ashton B.A., Kurtzberg L., Wozney J.M., Rosen V. Recombinant human bone morphogenetic protein-2 induces osteoblastic differentiation in W-20-17 stromal cells. Endocrinology. 130:1992;1318-1324.
5. Wang W., Mariani F.V., Harland R.M., Luo K. Ski represses bone morphogenic protein signaling in Xenopus and mammalian cells. Proc. Natl. Acad. Sci. USA. 97:2000;14394-14399.
6. Massague J., Blain S.W., Lo R.S. TGFbeta signaling in growth control, cancer, and heritable disorders. Cell. 103:2000;295-309.
7. Garcia Abreu J., Coffinier C., Larrain J., Oelgeschlager M., De Robertis E.M. Chordin-like CR domains and the regulation of evolutionarily conserved extracellular signaling systems. Gene. 287:2002;39-47.
8. Piccolo S., Sasai Y., Lu B., De Robertis E.M. Dorsoventral patterning in Xenopus: inhibition of ventral signals by direct binding of chordin to BMP-4. Cell. 86:1996;589-598.
9. Bachiller D., Klingensmith J., Kemp C., Belo J.A., Anderson R.M., May S.R., McMahon J.A., McMahon A.P., Harland R.M., Rossant J., De Robertis E.M. The organizer factors Chordin and Noggin are required for mouse forebrain development. Nature. 403:2000;658-661.
10. Balemans W., Van Hul W. Extracellular regulation of BMP signaling in vertebrates: a cocktail of modulators. Dev. Biol. 250:2002;231-250.
11. Larrain J., Bachiller D., Lu B., Agius E., Piccolo S., De Robertis E.M. BMP-binding modules in chordin: a model for signalling regulation in the extracellular space. Development. 127:2000;821-830.
12. Coffinier C., Ketpura N., Tran U., Geissert D., De Robertis E.M. Mouse Crossveinless-2 is the vertebrate homolog of a Drosophila extracellular regulator of BMP signaling. Gene Expr. Patterns. 2:2002;189-194.
13. Matsui M., Mizuseki K., Nakatani J., Nakanishi S., Sasai Y. Xenopus kielin: A dorsalizing factor containing multiple chordin-type repeats secreted from the embryonic midline. Proc. Natl. Acad. Sci. USA. 97:2000;5291-5296.
14. Nakayama N., Han C.E., Scully S., Nishinakamura R., He C., Zeni L., Yamane H., Chang D., Yu D., Yokota T., Wen D. A novel chordin-like protein inhibitor for bone morphogenetic proteins expressed preferentially in mesenchymal cell lineages. Dev. Biol. 232:2001;372-387.
15. Mabie P.C., Mehler M.F., Kessler J.A. Multiple roles of bone morphogenetic protein signaling in the regulation of cortical cell number and phenotype. J. Neurosci. 19:1999;7077-7088.
16. Ducy P., Karsenty G. Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene. Mol. Cell. Biol. 15:1995;1858-1869.
17. Valcourt U., Gouttenoire J., Aubert-Foucher E., Herbage D., Mallein-Gerin F. Alternative splicing of type II procollagen pre-mRNA in chondrocytes is oppositely regulated by BMP-2 and TGF-beta1. FEBS Lett. 545:2003;115-119.
18. Shukunami C., Ohta Y., Sakuda M., Hiraki Y. Sequential progression of the differentiation program by bone morphogenetic protein-2 in chondrogenic cell line ATDC5. Exp. Cell Res. 241:1998;1-11.
19. Vaananen K., Morris D.C., Munoz P.A., Parvinen E.K. Immunohistochemical study of alkaline phosphatase in growth plate cartilage, bone, and fetal calf isolated chondrocytes using monoclonal antibodies. Acta Histochem. 82:1987;211-217.
20. Shukunami C., Akiyama H., Nakamura T., Hiraki Y. Requirement of autocrine signaling by bone morphogenetic protein-4 for chondrogenic differentiation of ATDC5 cells. FEBS Lett. 469:2000;83-87.
21. Mason E.D., Konrad K.D., Webb C.D., Marsh J.L. Dorsal midline fate in Drosophila embryos requires twisted gastrulation, a gene encoding a secreted protein related to human connective tissue growth factor. Genes Dev. 8:1994;1489-1501.
22. Chang C., Holtzman D.A., Chau S., Chickering T., Woolf E.A., Holmgren L.M., Bodorova J., Gearing D.P., Holmes W.E., Brivanlou A.H. Twisted gastrulation can function as a BMP antagonist. Nature. 410:2001;483-487.
23. Harland R.M. Developmental biology. A twist on embryonic signalling. Nature. 410:2001;423-424.
24. Larrain J., Oelgeschlager M., Ketpura N.I., Reversade B., Zakin L., De Robertis E.M. Proteolytic cleavage of Chordin as a switch for the dual activities of twisted gastrulation in BMP signaling. Development. 128:2001;4439-4447.
25. Ross J.J., Shimmi O., Vilmos P., Petryk A., Kim H., Gaudenz K., Hermanson S., Ekker S.C., O'Connor M.B., Marsh J.L. Twisted gastrulation is a conserved extracellular BMP antagonist. Nature. 410:2001;479-483.
26. Yu K., Srinivasan S., Shimmi O., Biehs B., Rashka K.E., Kimelman D., O'Connor M.B., Bier E. Processing of the Drosophila Sog protein creates a novel BMP inhibitory activity. Development. 127:2000;2143-2154.
27. Constam D.B., Robertson E.J. Regulation of bone morphogenetic protein activity by pro domains and proprotein convertases. J. Cell Biol. 144:1999;139-149.
28. Perez-Vilar J., Hill R.L. The structure and assembly of secreted mucins. J. Biol. Chem. 274:1999;31751-31754.
29. Nakayama N., Han C.Y., Cam L., Lee J.I., Pretorius J., Fisher S., Rosenfeld R., Scully S., Nishinakamura R., Duryea D., Van G., Bolon B., Yokota T., Zhang K. A novel chordin-like BMP inhibitor, CHL2, expressed preferentially in chondrocytes of developing cartilage and osteoarthritic joint cartilage. Development. 131:2004;229-240.
30. Bellusci S., Henderson R., Winnier G., Oikawa T., Hogan B.L. Evidence from normal expression and targeted misexpression that bone morphogenetic protein (Bmp-4) plays a role in mouse embryonic lung morphogenesis. Development. 122:1996;1693-1702.
31. Lu M.M., Yang H., Zhang L., Shu W., Blair D.G., Morrisey E.E. The bone morphogenic protein antagonist gremlin regulates proximal-distal patterning of the lung. Dev. Dyn. 222:2001;667-680.
32. Mehler M.F., Mabie P.C., Zhang D., Kessler J.A. Bone morphogenetic proteins in the nervous system. Trends Neurosci. 20:1997;309-317.
33. Moser M., Binder O., Wu Y., Aitsebaomo J., Ren R., Bode C., Bautch V.L., Conlon F.L., Patterson C. BMPER, a novel endothelial cell precursor-derived protein, antagonizes bone morphogenetic protein signaling and endothelial cell differentiation. Mol. Cell. Biol. 23:2003;5664-5679.
34. Simpson D.A., Feeney S., Boyle C., Stitt A.W. Retinal VEGF mRNA measured by SYBR green I fluorescence: a versatile approach to quantitative PCR. Mol. Vis. 6:2000;178-183.
35. Gordon D., Abajian C., Green P. Consed: a graphical tool for sequence finishing. Genome Res. 8:1998;195-202.
36. Atsumi T., Miwa Y., Kimata K., Ikawa Y. A chondrogenic cell line derived from a differentiating culture of AT805 teratocarcinoma cells. Cell Differ. Dev. 30:1990;109-116.